- Earth Science Tech, an expanding health-based holding company, recently announced the acquisition of Meduvo LLC, a compounding pharmacy that currently operates from a 2,000-square-foot facility in La Verne, California
- The acquisition grows the company’s network to 34 jurisdictions in the United States and establishes a strategic West Coast operational hub
- In addition to Meduvo, ETST also operates other compounding pharmacies through its specialized subsidiaries RxCompoundStore.com LLC (“RxCS”) and Mister Meds LLC
Earth Science Tech (OTC: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, recently acquired Meduvo LLC, a compounding pharmacy. Meduvo currently operates from a 2,000-square-foot facility in La Verne, California, where it compounds and dispenses non-sterile medications. The acquisition expands the company’s already wide network to 34 jurisdictions in the United States and establishes a strategic West Coast operational hub (https://ibn.fm/UyyO2).
The recent acquisition aligns with Earth Science Tech’s focus on scaling its business by expanding its geographic footprint, advancing its popular telehealth and pharmacy fulfillment platforms. This focus is part of the company’s strategy to integrate the patient experience, from telemedicine to pharmacy to fulfilment, into a unified system to serve patients more effectively while building a stronger and more profitable operation (https://ibn.fm/GJNhV).
“Looking ahead, our core focus remains on optimizing the operational frameworks of our holdings to support scalable, sustainable expansion,” said Giorgio R. Saumat, CEO and Chairman of the Board, in his 2026 annual letter to shareholders (https://ibn.fm/MpgTz). “I expect every company under the ETST umbrella to expand its geographic footprint this year, and we will pursue acquisitions and/or partnerships where they help us meet that goal.”
Even with the acquisition complete, Earth Science Tech is still targeting further expansion and operational optimization: the company plans to capture broader market share and unlock long-term, high-margin revenue by initiating upgrades at Meduvo’s La Verne facility. The upgrades will ensure the facility meets strict sterility requirements, with ETST’s management targeting full regulatory certification for sterile compounding by the end of 2028.
Earth Science Tech operates other compounding pharmacies through its specialized subsidiaries, Miami-based RxCompoundStore.com LLC (“RxCS”) and Abilene, Texas-based Mister Meds LLC. RxCS provides sterile and non-sterile medications, while Mister Meds is licensed to handle hazardous drugs and compound sterile medication.
The addition of Meduvo into this existing network of compounding pharmacies means that the company can dispense medication across Alabama, Arizona, California, Colorado, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Maine, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Texas, Utah, Vermont, Virginia, Wisconsin, and Wyoming.
For more information, visit the company’s website at www.EarthScienceTech.com.
NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST
